via John Innes Centre
Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).
Researchers from the John Innes Centre evaluated two compounds with antibacterial properties, which had been produced by the company Redx Pharma as antibiotic candidates, particularly against TB.
TB, which is caused by the bacterium Mycobacterium tuberculosis, is often thought of as a disease of the past. But in recent years it has been increasing due, in part, to rising resistance to treatments and decreasing efficacy of vaccines.
One strategy in the search for new treatments is to find compounds that exploit well-known existing targets for drugs such as the bacterial enzyme DNA gyrase. This member of the DNA topoisomerase family of enzymes is required for bacterial DNA functionality, so compounds that inhibit its activity are much sought after as antibiotic candidates.
Using X-ray crystallography, the team elucidated the molecular details of the action of the compounds against their target.
Surprisingly, a very common mutation in DNA gyrase that causes bacteria to be resistant to a related group of antibiotics, the aminocoumarins, did not lead to resistance to the compounds under scrutiny here.
“We hope that companies and academic groups working to develop new antibiotics will find this study useful. It opens the way for further synthesis and investigation of compounds that interact with this target,” says Professor Tony Maxwell one of the authors of the study which appears in the Journal of Antimicrobial Chemotherapy.
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years.
World Health Organisation (WHO) figures reveal that each day over 4,000 people die from TB and 300,000 people fall ill from the disease. Nearly 500,000 people fell ill with drug-resistant TB in 2018.
Professor Maxwell says: “Antimicrobial resistance (AMR) is now well-recognised as one of the biggest problems facing us in the in the 21st Century. If we don’t find solutions to it soon, we could be looking at epidemics of bacterial disease going forward.”
“People know about the bubonic plague and other such terrible pestilence through studying history but it’s not overstating the case that bacterial diseases of this sort could reemerge if we do not have effective antibiotics. We must find a way of bringing together expertise from the academic and business sector towards decisive action.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Old vaccine for tuberculosis may help protect older people against COVID-19on August 5, 2021 at 7:47 am
A team of researchers from the CMR-National Institute for Research in Tuberculosis and the ICMR-National Institute of Epidemiology, both in India, has found evidence suggesting that an old vaccine ...
- WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosison August 5, 2021 at 5:43 am
WHO guidelines now include ROCHE’S diagnostic tests in an expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnostics ...
- AI helps triage tuberculosis patients on chest x-rayon August 5, 2021 at 12:36 am
An artificial intelligence (AI) model can accurately distinguish between active and healed tuberculosis on chest x-rays, according to a study published August 3 in Radiology.
- Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children.on August 4, 2021 at 10:14 pm
The Southeast Asian tuberculosis burden is high, and it remains unclear if urban indoor air pollution in this setting is exacerbating the epidemic. To determine the associations of latent tuberculosis ...
- Story from a survivor of tuberculosison August 4, 2021 at 3:46 pm
Mohammed Azam is a patient registered at Page Hall Medical Centre, a Deep End General Practice in one of the most deprived areas of Sheffield. He was diagnosed with pulmonary tuberculosis 2 years ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Report finds reducing primary care antibiotic use 'not enough' to halt antimicrobial resistanceon August 5, 2021 at 5:10 am
A new report led by researchers at Imperial College London has found that reducing antibiotic prescribing in primary care may not be enough alone to halt the rise in drug resistant Escherichia coli (E ...
- Reducing primary care antibiotic use may not be enough to counter antimicrobial resistanceon August 5, 2021 at 4:08 am
A new report led by researchers at Imperial College London has found that reducing antibiotic prescribing in primary care alone may not be enough to halt the rise in drug resistant Escherichia coli (E ...
- The pharmacist’s role in fighting antimicrobial resistanceon August 5, 2021 at 1:02 am
Misuse and abuse of antibiotics is fueling the silent pandemic of antimicrobial resistance. Many pharmacists in countries across the African continent dole out antibiotics to people coming into their ...
- Reducing antibiotic prescribing in primary care alone may not stop drug-resistant E. coli infectionson August 4, 2021 at 5:28 pm
Strategies to reduce antibiotic prescribing in primary care are insufficient alone to halt the rise in drug resistant E. coli infections in England, a new report concludes.
- The Dark Pill: A Race to Stop the Antibiotic Resistance Pandemicon August 4, 2021 at 4:39 pm
Antibiotic resistance is one of the most pressing public health challenges of the modern world. Each year millions of people suffer from an antibiotic-resistant infection, and numerous die. Battling ...